34P - Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor and synchronous axillary lymph node metastases in 159 breast cancer patients - indicating tumoral heterogeneity
Authors
- Laura Weydandt (Leipzig, Germany)
- Lars-Christian Horn (Leipzig, Germany)
- Bahriye Aktas (Leipzig, Germany)
Speakers
- Laura Weydandt (Leipzig, Germany)
35P - Downregulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in breast cancer: A new insight into the mechanism of induction of antitumor immunity
Authors
- Sanambar Sadighi (Tehran, Iran)
- Ramezanali Sharifian (Tehran, Iran)
- Monireh Kazemimanesh (Tehran, Iran)
- Ahad Muhammadnejad (Tehran, Iran)
- Saeid Amanpour (Tehran, Iran)
- Samad Muhammadnejad (Tehran, Iran)
Speakers
- Sanambar Sadighi (Tehran, Iran)
Biomarkers and translational research and precision medicine
No ePoster preview available
36P - Endocrine implications in male breast cancer in Bulgaria
Authors
- Assia A. Konsoulova-Kirova (Varna, Bulgaria)
- Kalin Kalchev (Varna, Bulgaria)
- Angel Yordanov (Pleven, Bulgaria)
- Samar El Shemeri (Varna, Bulgaria)
- Strahil A. Strashilov (Pleven, Bulgaria)
- Svilen I. Maslyankov (Sofia, Bulgaria)
- Kostadin G. Angelov (Sofia, Bulgaria)
- Dessislava Kostova-Lefterova (Pleven, Bulgaria)
- Yaroslava Marincheva (Burgas, Bulgaria)
- Mariela B. Vasileva (Sofia, Bulgaria)
Speakers
- Assia A. Konsoulova-Kirova (Varna, Bulgaria)
38P - Defining the physiological miRNA landscape in nipple aspirate fluid
Authors
- Susana I. Patuleia (Utrecht, Netherlands)
- Cathy B. Moelans (Utrecht, Netherlands)
- Carla H. Van Gils (Utrecht, Netherlands)
- Paul J. Van Diest (Utrecht, Netherlands)
- Elsken Van der Wall (Utrecht, Netherlands)
Speakers
- Susana I. Patuleia (Utrecht, Netherlands)
40P - WNT, Hedgehog and NOTCH signaling pathways in triple negative breast cancer with high and low content of cancer stem cells
Authors
- Aleksandr Brilliant (Ekaterinburg, Russian Federation)
- Yulia Brilliant (Ekaterinburg, Russian Federation)
- Sergey Sazonov (Ekaterinburg, Russian Federation)
Speakers
- Aleksandr Brilliant (Ekaterinburg, Russian Federation)
42P_PR - Painting the global picture of HER2-testing for breast cancer. The ONCOLLEGE-001 survey study
Authors
- Sara C. Altuna (Caracas, Venezuela)
- Csongor Lengyel (Budapest, Hungary)
- Dario Trapani (Milan, Italy)
- Essam M. Elfaham (Alexandria, Egypt)
- Sadaqat Hussain (Riyadh, Saudi Arabia)
- Angelica Petrillo (Napoli, Italy)
- Khalid El Bairi (Oujda, Morocco)
- Syed A. Mazher (Little Rock, United States of America)
- Baker S. Habeeb (Erbil, Iraq)
- Shah Zaib Khan (Peshawar, Pakistan)
Speakers
- Sara C. Altuna (Caracas, Venezuela)
43P - CIP2A as a novel target to combat basal like breast cancer
Authors
- Srikar Nagelli (Turku, Finland)
- Anni Laine (Amsterdam, Netherlands)
- Tomi Suomi (Turku, Finland)
- Laura Elo (Turku, Finland)
- Jukka Westermarck (Turku, Finland)
Speakers
- Srikar Nagelli (Turku, Finland)
46P - BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
Authors
- Eleonora Molinaro (Modena, Italy)
- Marta Venturelli (Modena, Italy)
- Angela Toss (Modena, Italy)
- Claudia Piombino (Modena, Italy)
- Elena Barbieri (Modena, Italy)
- Luigi Marcheselli (Modena, Italy)
- Isabella Marchi (Modena, Italy)
- Enrico Tagliafico (Modena, Italy)
- Stefano Cascinu (Modena, Italy)
- Laura Cortesi (Modena, Italy)
Speakers
- Eleonora Molinaro (Modena, Italy)
49P - The metastatic potential of grade I breast carcinoma of no special type: A deep insight into putative molecular mechanisms
Authors
- Francesca Lessi (San Giuliano Terme, Italy)
- Claudia Scopelliti (San Giuliano Terme, Italy)
- Paolo Aretini (San Giuliano Terme, Italy)
- Michele Menicagli (San Giuliano Terme, Italy)
- Sara Franceschi (San Giuliano Terme, Italy)
- Chiara M. Mazzanti (San Giuliano Terme, Italy)
- Antonio G. Naccarato (Pisa, Italy)
- Cristian Scatena (Pisa, Italy)
Speakers
- Francesca Lessi (San Giuliano Terme, Italy)
50P - ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy
Authors
- Diederick Keizer (Eindhoven, Netherlands)
- Marcia A. Inda (Eindhoven, Netherlands)
- Danielle Clout (Eindhoven, Netherlands)
- Anja Van de Stolpe (Eindhoven, Netherlands)
- Anu Fernando (Edinburgh, United Kingdom)
- Carlos Martinez-Perez (Edinburgh, United Kingdom)
- J. Michael Dixon (Edinburgh, United Kingdom)
- Andrew H. Sims (Edinburgh, United Kingdom)
- Arran K. Turnbull (Edinburgh, United Kingdom)
Speakers
- Diederick Keizer (Eindhoven, Netherlands)
51P - Higher ER load is not associated with better outcome in stage I-III breast cancer
Authors
- Iris Noordhoek (Leiden, Netherlands)
- Anne F. De Groot (Leiden, Netherlands)
- Danielle Cohen (Leiden, Netherlands)
- Gerrit-Jan Liefers (Leiden, Netherlands)
- Johanneke E. Portielje (Leiden, Netherlands)
- Judith R. Kroep (Leiden, Netherlands)
Speakers
- Iris Noordhoek (Leiden, Netherlands)
52P - The early changes of ΔSUV is a predictive marker of response and outcome in everolimus treated patients with mBC
Authors
- Marianna M. Sirico (Rome, Italy)
Speakers
- Marianna M. Sirico (Rome, Italy)